LeadingBiotech: Boston CEO is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Réka Shinkle, MBA
Vice President, Commercial and Portfolio Planning at REGENXBIO


Réka Shinkle joined REGENXBIO as the Vice President, Commercial and Portfolio Planning in April 2015. Previously, Ms. Shinkle held increasing commercial responsibility spanning small molecule and biologic products in multiple therapeutic areas at Lilly, MedImmune, and AstraZeneca. Ms. Shinkle’s current responsibilities include building the commercial function at REGENXBIO while ensuring development of insight-driven gene therapy portfolio and product strategies with line of sight to commercialization. Ms. Shinkle earned her Masters in Business Administration cum laude from the University of Michigan.

Réka Shinkle, MBA's Network

Agenda Sessions

  • Keynote Panel: Creative Pricing Models

    , 2:00pm